Byrne C[au] - Search Results

Year	Number of Results
1830	1
1953	1
1964	1
1967	1
1980	2
1981	2
1982	3
1983	5
1984	6
1985	5
1986	4
1987	8
1988	9
1989	3
1990	5
1991	16
1992	10
1993	5
1994	22
1995	18
1996	17
1997	25
1998	20
1999	27
2000	25
2001	27
2002	26
2003	16
2004	21
2005	36
2006	29
2007	38
2008	25
2009	37
2010	38
2011	24
2012	44
2013	46
2014	53
2015	57
2016	48
2017	58
2018	75
2019	95
2020	108
2021	61

1

NAFLD: a multisystem disease.

Byrne CD, Targher G. Byrne CD, et al. J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012. J Hepatol. 2015. PMID: 25920090 Free article. Review.

2

Nonalcoholic Fatty Liver Disease in Children.

Mann JP, Valenti L, Scorletti E, Byrne CD, Nobili V. Mann JP, et al. Among authors: byrne cd. Semin Liver Dis. 2018 Feb;38(1):1-13. doi: 10.1055/s-0038-1627456. Epub 2018 Feb 22. Semin Liver Dis. 2018. PMID: 29471561 Free article. Review.

3

The impact of electronic health records on diagnosis.

Graber ML, Byrne C, Johnston D. Graber ML, et al. Among authors: byrne c. Diagnosis (Berl). 2017 Nov 27;4(4):211-223. doi: 10.1515/dx-2017-0012. Diagnosis (Berl). 2017. PMID: 29536944 Free article. Review.

4

Prognostic factors for recovery following acute lateral ankle ligament sprain: a systematic review.

Thompson JY, Byrne C, Williams MA, Keene DJ, Schlussel MM, Lamb SE. Thompson JY, et al. Among authors: byrne c. BMC Musculoskelet Disord. 2017 Oct 23;18(1):421. doi: 10.1186/s12891-017-1777-9. BMC Musculoskelet Disord. 2017. PMID: 29061135 Free PMC article. Review.

5

COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.

Feng G, Zheng KI, Yan QQ, Rios RS, Targher G, Byrne CD, Poucke SV, Liu WY, Zheng MH. Feng G, et al. Among authors: byrne cd. J Clin Transl Hepatol. 2020 Mar 28;8(1):18-24. doi: 10.14218/JCTH.2020.00018. Epub 2020 Mar 30. J Clin Transl Hepatol. 2020. PMID: 32274342 Free PMC article. Review.

6

Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors.

Francque S, Szabo G, Abdelmalek MF, Byrne CD, Cusi K, Dufour JF, Roden M, Sacks F, Tacke F. Francque S, et al. Among authors: byrne cd. Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):24-39. doi: 10.1038/s41575-020-00366-5. Epub 2020 Oct 22. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33093663 Review.

7

Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma.

Richardson PG, Oriol A, Larocca A, Bladé J, Cavo M, Rodriguez-Otero P, Leleu X, Nadeem O, Hiemenz JW, Hassoun H, Touzeau C, Alegre A, Paner A, Maisel C, Mazumder A, Raptis A, Moreb JS, Anderson KC, Laubach JP, Thuresson S, Thuresson M, Byrne C, Harmenberg J, Bakker NA, Mateos MV; HORIZON (OP-106) Investigators. Richardson PG, et al. Among authors: byrne c. J Clin Oncol. 2021 Mar 1;39(7):757-767. doi: 10.1200/JCO.20.02259. Epub 2020 Dec 9. J Clin Oncol. 2021. PMID: 33296242 Free article.

8

Diagnosis and management of non-alcoholic fatty liver disease.

Jennison E, Patel J, Scorletti E, Byrne CD. Jennison E, et al. Among authors: byrne cd. Postgrad Med J. 2019 Jun;95(1124):314-322. doi: 10.1136/postgradmedj-2018-136316. Epub 2019 May 13. Postgrad Med J. 2019. PMID: 31085617 Review.

9

Non-alcoholic fatty liver disease and childhood obesity.

Shaunak M, Byrne CD, Davis N, Afolabi P, Faust SN, Davies JH. Shaunak M, et al. Among authors: byrne cd. Arch Dis Child. 2021 Jan;106(1):3-8. doi: 10.1136/archdischild-2019-318063. Epub 2020 May 14. Arch Dis Child. 2021. PMID: 32409495 Review.

10

What's new in NAFLD pathogenesis, biomarkers and treatment?

Byrne CD, Targher G. Byrne CD, et al. Nat Rev Gastroenterol Hepatol. 2020 Feb;17(2):70-71. doi: 10.1038/s41575-019-0239-2. Nat Rev Gastroenterol Hepatol. 2020. PMID: 31740806 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results